Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Pyrimethamine in Healthy Japanese and Caucasian Males
NCT03258762Phase 1Completed
- Sponsor
- GSK
- Start
- Sep 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of pyrimethamine in toxoplasmosis (2 arms), sponsored by GSK. Primary endpoints: Maximum Observed Concentration at Day 22, Area Under the Concentration-time Curve From Time 0 to t at Day 22 and 6 more. Started Sep 2017; status: completed.
02
Drugs
pyrimethamine
03
Conditions
toxoplasmosis
Beyond the preview
Go deeper on NCT03258762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03258762.